Search Results - "Haughey, Mary"

CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis by Glasgow, Connie G., Pacheco-Rodriguez, Gustavo, Steagall, Wendy K., Haughey, Mary E., Julien-Williams, Patricia A., Stylianou, Mario P., Gochuico, Bernadette R., Moss, Joel

“…Lymphangioleiomyomatosis (LAM) is a destructive lung disease of women caused by proliferation of neoplastic-like LAM cells, with mutations in the TSC1/2 tumor…”
Get full text

Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus by Nathan, Neera, BA, Wang, Ji-an, AS, Li, Shaowei, MD, PhD, Cowen, Edward W., MD, MHSc, Haughey, Mary, RN, Moss, Joel, MD, PhD, Darling, Thomas N., MD, PhD

“…Background Oral mechanistic target of rapamycin inhibitors have been shown to reduce visceral tumor volume in patients with tuberous sclerosis complex (TSC)…”
Get full text

Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis by Cai, Xiong, PhD, Pacheco-Rodriguez, Gustavo, PhD, Haughey, Mary, RN, BSN, Samsel, Leigh, MS, Xu, Suowen, PhD, Wu, Hai-Ping, BS, McCoy, J. Philip, PhD, Stylianou, Mario, PhD, Darling, Thomas N., MD, PhD, Moss, Joel, MD, PhD, FCCP

“…Background Lymphangioleiomyomatosis (LAM), sporadic or in women with tuberous sclerosis complex (TSC), is characterized by cystic lung destruction, lymphatic…”
Get full text

Natural History of Pulmonary Fibrosis in Two Subjects With the Same Telomerase Mutation by El-Chemaly, Souheil, Dr, Ziegler, Shira G., Ms, Calado, Rodrigo T., Dr, Wilson, Kirkland A., Mr, Wu, Hai Ping, Ms, Haughey, Mary, Dr, Peterson, Nathan R., Dr, Young, Neal S., Dr, Gahl, William A., Dr, Moss, Joel, Dr, Gochuico, Bernadette R., Dr

“…Previous studies have identified subclinical lung disease in family members of probands with familial pulmonary fibrosis, but the natural history of…”
Get full text

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial by El-Chemaly, Souheil, Taveira-Dasilva, Angelo, Goldberg, Hilary J, Peters, Elizabeth, Haughey, Mary, Bienfang, Don, Jones, Amanda M, Julien-Williams, Patricia, Cui, Ye, Villalba, Julian A, Bagwe, Shefali, Maurer, Rie, Rosas, Ivan O, Moss, Joel, Henske, Elizabeth P

“…Animal and cellular studies support the importance of autophagy inhibition in lymphangioleiomyomatosis (LAM). In a cohort of subjects with LAM, we tested the…”
Get full text

BRAF and NRAS mutations in circulating Langerhans-like CD1a + cells in a patient with pulmonary Langerhans' cell histiocytosis by Zhang, Li, Pacheco-Rodriguez, Gustavo, Steagall, Wendy K, Kato, Jiro, Colby, Thomas V, Haughey, Mary, Moss, Joel

“…Pulmonary Langerhans’ cell histiocytosis (PLCH) presents as accumulation of Langerhans’ cells and other langerin-expressing dendritic cells (LCH cells) in the…”
Get full text

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis by Cai, Xiong, Pacheco-Rodriguez, Gustavo, Fan, Qing-Yuan, Haughey, Mary, Samsel, Leigh, El-Chemaly, Souheil, Wu, Hai-Ping, McCoy, J Philip, Steagall, Wendy K, Lin, Jing-Ping, Darling, Thomas N, Moss, Joel

“…Lymphangioleiomyomatosis (LAM), occurring sporadically (S-LAM) or in patients with tuberous sclerosis complex (TSC), results from abnormal proliferation of LAM…”
Get full text

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis by El-Chemaly, Souheil, Taveira-Dasilva, Angelo, Goldberg, Hilary J., Peters, Elizabeth, Haughey, Mary, Bienfang, Don, Jones, Amanda M., Julien-Williams, Patricia, Cui, Ye, Villalba, Julian A., Bagwe, Shefali, Maurer, Rie, Rosas, Ivan O., Moss, Joel, Henske, Elizabeth P.

“…Animal and cellular studies support the importance of autophagy inhibition in lymphangioleiomyomatosis (LAM). In a cohort of subjects with LAM, we tested the…”
Get full text

Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer by Zhang, Li, Pacheco-Rodriguez, Gustavo, Steagall, Wendy K, Kato, Jiro, Haughey, Mary, Fontana, Joseph R, Manganiello, Vincent C, Moss, Joel

Get full text

Personal stories: voices of Latino youth health advocates in a diabetes prevention initiative by Toussaint, Danielle W, Villagrana, Maria, Mora-Torres, Hugo, de Leon, Mario, Haughey, Mary Hoshiko

“…The YMCA-Silicon Valley Racial and Ethnic Approaches to Community Health (REACH) U.S. Proyecto Movimiento (PM) Action Community project is a community-based…”
Get more information

Phenotypic Characterization of Disseminated Cells with TSC2 Loss of Heterozygosity in Patients with Lymphanioleiomyomatosis by XIONG CAI, PACHECO-RODRIGUEZ, Gustavo, DARLING, Thomas N, MOSS, Joel, FAN, Qing-Yuan, HAUGHEY, Mary, SAMSEL, Leigh, EL-CHEMALY, Souheil, WU, Hai-Ping, PHILIP MCCOY, J, STEAGALL, Wendy K, LIN, Jing-Ping

Get full text

Urinary excretion of aquaporin-2 in humans: a potential marker of collecting duct responsiveness to vasopressin by Elliot, S, Goldsmith, P, Knepper, M, Haughey, M, Olson, B

“…The vasopressin-sensitive water channel (aquaporin 2; AQP-2) mediates water transport across the apical plasma membrane of the renal collecting ducts and is…”
Get full text

A Non-Traditional Fluency Program Developed for the Public School Setting by Berkowitz, Mozelle

“…This article presents a service delivery model for treating schoolchildren who stutter, involving weekly treatment sessions with groups of students after the…”
Get more information